Stay updated on All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial
Sign up to get notified when there's something new on the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page.

Latest updates to the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 added; Interstitial lung disease 2 and the Genetic and Rare Diseases Information Center resource were removed. Revision: v3.4.3 indicates the previous version.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.4.2 is added; the notices Revision: v3.4.1 and the government funding status notice have been removed. These are administrative updates to the site and do not alter the study details or participation requirements.SummaryDifference0.5%

- Check51 days agoChange DetectedAdded a site-wide notice about government funding lapse and the NIH Clinical Center status, and updated the revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check58 days agoChange DetectedUI updates include showing the glossary toggle and minor wording changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with the revision note 'v3.4.0' replacing 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a small UI/metadata update.SummaryDifference0.1%

Stay in the know with updates to All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page.